Crosstalk between Regulatory T Cells and Tumor-Associated Dendritic Cells Negates Anti-tumor Immunity in Pancreatic Cancer

Cell Reports

Volumn 20, Issue 3, 2017, Pages 558-571

  Jang, Jung Eun ^a   Hajdu, Cristina H ^a   Liot, Caroline ^a   Miller, George ^a   Dustin, Michael L ^a,b   Bar Sagi, Dafna ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

anti tumor immunity; pancreatic ductal adenocarcinoma; regulatory T cells; tolerance; tumor associated dendritic cells

Indexed keywords

GAMMA INTERFERON; GLYCOPROTEIN P 15095; IFNG PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; CD8+ T LYMPHOCYTE; CELL INTERACTION; CONTROLLED STUDY; CYTOKINE RESPONSE; DENDRITIC CELL; FEMALE; IMMUNOGENICITY; IMMUNOLOGICAL TOLERANCE; MALE; MOUSE; NONHUMAN; PANCREAS ADENOCARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; TUMOR ASSOCIATED LEUKOCYTE; TUMOR IMMUNITY; ANIMAL; CELLULAR IMMUNITY; GENETICS; IMMUNOLOGY; PANCREAS TUMOR; PATHOLOGY; TRANSGENIC MOUSE;

ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; DENDRITIC CELLS; IMMUNITY, CELLULAR; INTERFERON-GAMMA; MICE; MICE, TRANSGENIC; PANCREATIC NEOPLASMS; T-LYMPHOCYTES, REGULATORY;

EID: 85025109012     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2017.06.062     Document Type: Article

References (56)

1. Bauer, C.A., Kim, E.Y., Marangoni, F., Carrizosa, E., Claudio, N.M., Mempel, T.R., Dynamic Treg interactions with intratumoral APCs promote local CTL dysfunction. J. Clin. Invest. 124 (2014), 2425–2440.
2. Bayne, L.J., Beatty, G.L., Jhala, N., Clark, C.E., Rhim, A.D., Stanger, B.Z., Vonderheide, R.H., Tumor-derived granulocyte-macrophage colony-stimulating factor regulates myeloid inflammation and T cell immunity in pancreatic cancer. Cancer Cell 21 (2012), 822–835.
3. Bettelli, E., Carrier, Y., Gao, W., Korn, T., Strom, T.B., Oukka, M., Weiner, H.L., Kuchroo, V.K., Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441 (2006), 235–238.
4. Boissonnas, A., Scholer-Dahirel, A., Simon-Blancal, V., Pace, L., Valet, F., Kissenpfennig, A., Sparwasser, T., Malissen, B., Fetler, L., Amigorena, S., Foxp3+ T cells induce perforin-dependent dendritic cell death in tumor-draining lymph nodes. Immunity 32 (2010), 266–278.
5. Bos, P.D., Plitas, G., Rudra, D., Lee, S.Y., Rudensky, A.Y., Transient regulatory T cell ablation deters oncogene-driven breast cancer and enhances radiotherapy. J. Exp. Med. 210 (2013), 2435–2466.
6. Byrne, K.T., Vonderheide, R.H., CD40 stimulation obviates innate sensors and drives T cell immunity in cancer. Cell Rep. 15 (2016), 2719–2732.
7. Cederbom, L., Hall, H., Ivars, F., CD4+CD25+ regulatory T cells down-regulate co-stimulatory molecules on antigen-presenting cells. Eur. J. Immunol. 30 (2000), 1538–1543.
8. Clark, C.E., Hingorani, S.R., Mick, R., Combs, C., Tuveson, D.A., Vonderheide, R.H., Dynamics of the immune reaction to pancreatic cancer from inception to invasion. Cancer Res. 67 (2007), 9518–9527.
9. Daley, D., Zambirinis, C.P., Seifert, L., Akkad, N., Mohan, N., Werba, G., Barilla, R., Torres-Hernandez, A., Hundeyin, M., Mani, V.R., et al. γδ T cells support pancreatic oncogenesis by restraining αβ T cell activation. Cell 166 (2016), 1485–1499.
10. Darrasse-Jèze, G., Bergot, A.S., Durgeau, A., Billiard, F., Salomon, B.L., Cohen, J.L., Bellier, B., Podsypanina, K., Klatzmann, D., Tumor emergence is sensed by self-specific CD44hi memory Tregs that create a dominant tolerogenic environment for tumors in mice. J. Clin. Invest. 119 (2009), 2648–2662.
11. Delgoffe, G.M., Woo, S.R., Turnis, M.E., Gravano, D.M., Guy, C., Overacre, A.E., Bettini, M.L., Vogel, P., Finkelstein, D., Bonnevier, J., et al. Stability and function of regulatory T cells is maintained by a neuropilin-1-semaphorin-4a axis. Nature 501 (2013), 252–256.
12. Fallarino, F., Grohmann, U., Hwang, K.W., Orabona, C., Vacca, C., Bianchi, R., Belladonna, M.L., Fioretti, M.C., Alegre, M.L., Puccetti, P., Modulation of tryptophan catabolism by regulatory T cells. Nat. Immunol. 4 (2003), 1206–1212.
13. Ghiringhelli, F., Puig, P.E., Roux, S., Parcellier, A., Schmitt, E., Solary, E., Kroemer, G., Martin, F., Chauffert, B., Zitvogel, L., Tumor cells convert immature myeloid dendritic cells into TGF-beta-secreting cells inducing CD4+CD25+ regulatory T cell proliferation. J. Exp. Med. 202 (2005), 919–929.
14. Guerra, C., Schuhmacher, A.J., Cañamero, M., Grippo, P.J., Verdaguer, L., Pérez-Gallego, L., Dubus, P., Sandgren, E.P., Barbacid, M., Chronic pancreatitis is essential for induction of pancreatic ductal adenocarcinoma by K-Ras oncogenes in adult mice. Cancer Cell 11 (2007), 291–302.
15. Hansen, W., Hutzler, M., Abel, S., Alter, C., Stockmann, C., Kliche, S., Albert, J., Sparwasser, T., Sakaguchi, S., Westendorf, A.M., et al. Neuropilin 1 deficiency on CD4+Foxp3+ regulatory T cells impairs mouse melanoma growth. J. Exp. Med. 209 (2012), 2001–2016.
16. Hiraoka, N., Onozato, K., Kosuge, T., Hirohashi, S., Prevalence of FOXP3+ regulatory T cells increases during the progression of pancreatic ductal adenocarcinoma and its premalignant lesions. Clin. Cancer Res. 12 (2006), 5423–5434.
17. Hori, S., Nomura, T., Sakaguchi, S., Control of regulatory T cell development by the transcription factor Foxp3. Science 299 (2003), 1057–1061.
18. Josefowicz, S.Z., Lu, L.F., Rudensky, A.Y., Regulatory T cells: mechanisms of differentiation and function. Annu. Rev. Immunol. 30 (2012), 531–564.
19. Joshi, N.S., Akama-Garren, E.H., Lu, Y., Lee, D.Y., Chang, G.P., Li, A., DuPage, M., Tammela, T., Kerper, N.R., Farago, A.F., et al. Regulatory T Cells in Tumor-Associated Tertiary Lymphoid Structures Suppress Anti-tumor T Cell Responses. Immunity 43 (2015), 579–590.
20. Keenan, B.P., Saenger, Y., Kafrouni, M.I., Leubner, A., Lauer, P., Maitra, A., Rucki, A.A., Gunderson, A.J., Coussens, L.M., Brockstedt, D.G., et al. A Listeria vaccine and depletion of T-regulatory cells activate immunity against early stage pancreatic intraepithelial neoplasms and prolong survival of mice. Gastroenterology 146 (2014), 1784–1794.
21. Keir, M.E., Butte, M.J., Freeman, G.J., Sharpe, A.H., PD-1 and its ligands in tolerance and immunity. Annu. Rev. Immunol. 26 (2008), 677–704.
22. Kim, J.M., Rasmussen, J.P., Rudensky, A.Y., Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice. Nat. Immunol. 8 (2007), 191–197.
23. Larmonier, N., Marron, M., Zeng, Y., Cantrell, J., Romanoski, A., Sepassi, M., Thompson, S., Chen, X., Andreansky, S., Katsanis, E., Tumor-derived CD4(+)CD25(+) regulatory T cell suppression of dendritic cell function involves TGF-beta and IL-10. Cancer Immunol. Immunother. 56 (2007), 48–59.
24. Leao, I.C., Ganesan, P., Armstrong, T.D., Jaffee, E.M., Effective depletion of regulatory T cells allows the recruitment of mesothelin-specific CD8 T cells to the antitumor immune response against a mesothelin-expressing mouse pancreatic adenocarcinoma. Clin. Transl. Sci. 1 (2008), 228–239.
25. Lindquist, R.L., Shakhar, G., Dudziak, D., Wardemann, H., Eisenreich, T., Dustin, M.L., Nussenzweig, M.C., Visualizing dendritic cell networks in vivo. Nat. Immunol. 5 (2004), 1243–1250.
26. Lo, A., Wang, L.C., Scholler, J., Monslow, J., Avery, D., Newick, K., O'Brien, S., Evans, R.A., Bajor, D.J., Clendenin, C., et al. Tumor-promoting desmoplasia is disrupted by depleting FAP-expressing stromal cells. Cancer Res. 75 (2015), 2800–2810.
27. Lunardi, S., Lim, S.Y., Muschel, R.J., Brunner, T.B., IP-10/CXCL10 attracts regulatory T cells: Implication for pancreatic cancer. OncoImmunology, 4, 2015, e1027473.
28. Maldonado, R.A., von Andrian, U.H., How tolerogenic dendritic cells induce regulatory T cells. Adv. Immunol. 108 (2010), 111–165.
29. Markowitz, J., Brooks, T.R., Duggan, M.C., Paul, B.K., Pan, X., Wei, L., Abrams, Z., Luedke, E., Lesinski, G.B., Mundy-Bosse, B., et al. Patients with pancreatic adenocarcinoma exhibit elevated levels of myeloid-derived suppressor cells upon progression of disease. Cancer Immunol. Immunother. 64 (2015), 149–159.
30. Munn, D.H., Mellor, A.L., IDO in the tumor microenvironment: inflammation, counter-regulation, and tolerance. Trends Immunol. 37 (2016), 193–207.
31. Munn, D.H., Sharma, M.D., Lee, J.R., Jhaver, K.G., Johnson, T.S., Keskin, D.B., Marshall, B., Chandler, P., Antonia, S.J., Burgess, R., et al. Potential regulatory function of human dendritic cells expressing indoleamine 2,3-dioxygenase. Science 297 (2002), 1867–1870.
32. Nishikawa, H., Sakaguchi, S., Regulatory T cells in tumor immunity. Int. J. Cancer 127 (2010), 759–767.
33. Onishi, Y., Fehervari, Z., Yamaguchi, T., Sakaguchi, S., Foxp3+ natural regulatory T cells preferentially form aggregates on dendritic cells in vitro and actively inhibit their maturation. Proc. Natl. Acad. Sci. USA 105 (2008), 10113–10118.
34. Pinzon-Charry, A., Maxwell, T., López, J.A., Dendritic cell dysfunction in cancer: a mechanism for immunosuppression. Immunol. Cell Biol. 83 (2005), 451–461.
35. Pylayeva-Gupta, Y., Lee, K.E., Hajdu, C.H., Miller, G., Bar-Sagi, D., Oncogenic Kras-induced GM-CSF production promotes the development of pancreatic neoplasia. Cancer Cell 21 (2012), 836–847.
36. Pylayeva-Gupta, Y., Lee, K.E., Bar-Sagi, D., Microdissection and culture of murine pancreatic ductal epithelial cells. Methods Mol. Biol. 980 (2013), 267–279.
37. Qureshi, O.S., Zheng, Y., Nakamura, K., Attridge, K., Manzotti, C., Schmidt, E.M., Baker, J., Jeffery, L.E., Kaur, S., Briggs, Z., et al. Trans-endocytosis of CD80 and CD86: a molecular basis for the cell-extrinsic function of CTLA-4. Science 332 (2011), 600–603.
38. Ryan, D.P., Hong, T.S., Bardeesy, N., Pancreatic adenocarcinoma. N. Engl. J. Med. 371 (2014), 1039–1049.
39. Sarris, M., Andersen, K.G., Randow, F., Mayr, L., Betz, A.G., Neuropilin-1 expression on regulatory T cells enhances their interactions with dendritic cells during antigen recognition. Immunity 28 (2008), 402–413.
40. Scarlett, U.K., Rutkowski, M.R., Rauwerdink, A.M., Fields, J., Escovar-Fadul, X., Baird, J., Cubillos-Ruiz, J.R., Jacobs, A.C., Gonzalez, J.L., Weaver, J., et al. Ovarian cancer progression is controlled by phenotypic changes in dendritic cells. J. Exp. Med. 209 (2012), 495–506.
41. Schildknecht, A., Brauer, S., Brenner, C., Lahl, K., Schild, H., Sparwasser, T., Probst, H.C., van den Broek, M., FoxP3+ regulatory T cells essentially contribute to peripheral CD8+ T-cell tolerance induced by steady-state dendritic cells. Proc. Natl. Acad. Sci. USA 107 (2010), 199–203.
42. Schlecker, E., Stojanovic, A., Eisen, C., Quack, C., Falk, C.S., Umansky, V., Cerwenka, A., Tumor-infiltrating monocytic myeloid-derived suppressor cells mediate CCR5-dependent recruitment of regulatory T cells favoring tumor growth. J. Immunol. 189 (2012), 5602–5611.
43. Shang, B., Liu, Y., Jiang, S.J., Liu, Y., Prognostic value of tumor-infiltrating FoxP3+ regulatory T cells in cancers: a systematic review and meta-analysis. Sci. Rep., 5, 2015, 15179.
44. Shankaran, V., Ikeda, H., Bruce, A.T., White, J.M., Swanson, P.E., Old, L.J., Schreiber, R.D., IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity. Nature 410 (2001), 1107–1111.
45. Sharma, M.D., Baban, B., Chandler, P., Hou, D.Y., Singh, N., Yagita, H., Azuma, M., Blazar, B.R., Mellor, A.L., Munn, D.H., Plasmacytoid dendritic cells from mouse tumor-draining lymph nodes directly activate mature Tregs via indoleamine 2,3-dioxygenase. J. Clin. Invest. 117 (2007), 2570–2582.
46. Sharma, M.D., Shinde, R., McGaha, T.L., Huang, L., Holmgaard, R.B., Wolchok, J.D., Mautino, M.R., Celis, E., Sharpe, A.H., Francisco, L.M., The PTEN pathway in Tregs is a critical driver of the suppressive tumor microenvironment. Sci. Adv., 1, 2015, e1500845.
47. Steinman, R.M., Hawiger, D., Nussenzweig, M.C., Tolerogenic dendritic cells. Annu. Rev. Immunol. 21 (2003), 685–711.
48. Stromnes, I.M., DelGiorno, K.E., Greenberg, P.D., Hingorani, S.R., Stromal reengineering to treat pancreas cancer. Carcinogenesis 35 (2014), 1451–1460.
49. Tan, M.C., Goedegebuure, P.S., Belt, B.A., Flaherty, B., Sankpal, N., Gillanders, W.E., Eberlein, T.J., Hsieh, C.S., Linehan, D.C., Disruption of CCR5-dependent homing of regulatory T cells inhibits tumor growth in a murine model of pancreatic cancer. J. Immunol. 182 (2009), 1746–1755.
50. Tang, Q., Adams, J.Y., Tooley, A.J., Bi, M., Fife, B.T., Serra, P., Santamaria, P., Locksley, R.M., Krummel, M.F., Bluestone, J.A., Visualizing regulatory T cell control of autoimmune responses in nonobese diabetic mice. Nat. Immunol. 7 (2006), 83–92.
51. Tang, Y., Xu, X., Guo, S., Zhang, C., Tang, Y., Tian, Y., Ni, B., Lu, B., Wang, H., An increased abundance of tumor-infiltrating regulatory T cells is correlated with the progression and prognosis of pancreatic ductal adenocarcinoma. PLoS ONE, 9, 2014, e91551.
52. Teng, M.W., Ngiow, S.F., von Scheidt, B., McLaughlin, N., Sparwasser, T., Smyth, M.J., Conditional regulatory T-cell depletion releases adaptive immunity preventing carcinogenesis and suppressing established tumor growth. Cancer Res. 70 (2010), 7800–7809.
53. Vonderheide, R.H., Bayne, L.J., Inflammatory networks and immune surveillance of pancreatic carcinoma. Curr. Opin. Immunol. 25 (2013), 200–205.
54. Weiss, J.M., Bilate, A.M., Gobert, M., Ding, Y., Curotto de Lafaille, M.A., Parkhurst, C.N., Xiong, H., Dolpady, J., Frey, A.B., Ruocco, M.G., et al. Neuropilin 1 is expressed on thymus-derived natural regulatory T cells, but not mucosa-generated induced Foxp3+ T reg cells. J. Exp. Med. 209 (2012), 1723–1742.
55. Wing, K., Onishi, Y., Prieto-Martin, P., Yamaguchi, T., Miyara, M., Fehervari, Z., Nomura, T., Sakaguchi, S., CTLA-4 control over Foxp3+ regulatory T cell function. Science 322 (2008), 271–275.
56. Yang, A.S., Lattime, E.C., Tumor-induced interleukin 10 suppresses the ability of splenic dendritic cells to stimulate CD4 and CD8 T-cell responses. Cancer Res. 63 (2003), 2150–2157.